{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:13:17Z","timestamp":1793153597037,"version":"4.5.0"},"reference-count":0,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Many immunotherapies focus on (re)invigorating CD8+ T cell anti-cancer responses. Different nuclear imaging techniques have been developed to measure CD8+ T cell distributions. Comprehensive comparisons of in vivo and ex vivo T cell labeling methods with respect to tumor and normal tissue targeting and correlation with CD8\u207a T cell presence are lacking, but essential for accurate clinical interpretation. We performed a head-to-head comparison of three CD8+ T cell imaging approaches: 89Zr-labeled Fc-silent anti-CD8 antibody ([89Zr]Zr-anti-CD8-IgG2asilent), ex vivo 89Zr-labeled ovalbumin-specific CD8+ T cells ([89Zr]Zr-OT-I), and 18F-labeled IL2 ([18F]AlF-RESCA-IL2).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>B16F10\/OVA tumor-bearing C57BL\/6 mice (n=10\/group) underwent PET\/CT imaging at 72 ([89Zr]Zr-anti-CD8-IgG2asilent), 24 and 48\u00a0h ([89Zr]Zr-OT-I), and 10\u00a0min ([18F]AlF-RESCA-IL2) pi. Subsequently, biodistribution analysis was performed followed by flow cytometry to evaluate intratumoral CD8+ T cell numbers. Intratumoral radiolabel distributions were assessed by autoradiography and immunohistochemistry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>All approaches showed uptake in CD8-rich tissues, with preferential spleen targeting. Biodistribution analyses showed tumor uptake exceeded blood level for [89Zr]Zr-anti-CD8-IgG2asilent and [89Zr]Zr-OT-I. Furthermore, their tumor uptake correlated to intratumoral CD8+ T cells presence even though intratumoral distribution patterns differed significantly.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>[89Zr]Zr-anti-CD8-IgG2asilent and [89Zr]Zr-OT-I PET\/CT imaging can evaluate intratumoral CD8+ T cell infiltration. [89Zr]Zr-anti-CD8-IgG2asilent might be suited for TME immunophenotyping, while ex vivo labeling visualizes tumor migration and invasion dynamics of tumor-specific T cells. [18F]AlF-RESCA-IL2 uptake did not correlate to the intratumoral CD8+ T cell presence. Here, we provide new insights to guide the selection of imaging strategies for assessing relevant immunotherapy-specific aspects of the TME and support correct interpretation of clinical CD8 imaging.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/immadv\/ltaf027","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T11:25:24Z","timestamp":1753701924000},"source":"Crossref","is-referenced-by-count":2,"title":["Head-to-head comparison of nuclear imaging approaches to quantify tumor CD8+ T-cell infiltration"],"prefix":"10.1093","author":[{"given":"Gerwin G W","family":"Sandker","sequence":"first","affiliation":[{"name":"Department of Medical Imaging, Radboud university medical center, Geert Grooteplein-Zuid 10 , 6525 HP Nijmegen, the","place":["Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Raav\u00e9","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Radboud university medical center, Geert Grooteplein-Zuid 10 , 6525 HP Nijmegen, the","place":["Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas F","family":"Antunes","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen , Antonius Deusinglaan 1, 9713 GZ Groningen, the","place":["Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milou","family":"Boswinkel","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Radboud university medical center, Geert Grooteplein-Zuid 10 , 6525 HP Nijmegen, the","place":["Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenneke","family":"Cornelissen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Radiotherapy & OncoImmunology lab, Radboud university medical center , Geert Grooteplein-Zuid 10, 6525 HP Nijmegen, the","place":["Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerben M","family":"Franssen","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Radboud university medical center, Geert Grooteplein-Zuid 10 , 6525 HP Nijmegen, the","place":["Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke","family":"Molkenboer-Kuenen","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Radboud university medical center, Geert Grooteplein-Zuid 10 , 6525 HP Nijmegen, the","place":["Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J","family":"Wierstra","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Radboud university medical center, Geert Grooteplein-Zuid 10 , 6525 HP Nijmegen, the","place":["Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris M","family":"Hagemans","sequence":"additional","affiliation":[{"name":"Department of Tumor Immunology and the Institute for Chemical Immunology, Radboud university medical center, Geert Grooteplein 26 , 6525 GA Nijmegen, the","place":["Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik F J","family":"de Vries","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen , Antonius Deusinglaan 1, 9713 GZ Groningen, the","place":["Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Bussink","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Radiotherapy & OncoImmunology lab, Radboud university medical center , Geert Grooteplein-Zuid 10, 6525 HP Nijmegen, the","place":["Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gosse","family":"Adema","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Radiotherapy & OncoImmunology lab, Radboud university medical center , Geert Grooteplein-Zuid 10, 6525 HP Nijmegen, the","place":["Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"Verdoes","sequence":"additional","affiliation":[{"name":"Department of Tumor Immunology and the Institute for Chemical Immunology, Radboud university medical center, Geert Grooteplein 26 , 6525 GA Nijmegen, the","place":["Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3809-0182","authenticated-orcid":false,"given":"Erik H J G","family":"Aarntzen","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Radboud university medical center, Geert Grooteplein-Zuid 10 , 6525 HP Nijmegen, the","place":["Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Heskamp","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Radboud university medical center, Geert Grooteplein-Zuid 10 , 6525 HP Nijmegen, the","place":["Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,7,28]]},"container-title":["Immunotherapy Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/immunotherapyadv\/advance-article-pdf\/doi\/10.1093\/immadv\/ltaf027\/63883959\/ltaf027.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/immunotherapyadv\/advance-article-pdf\/doi\/10.1093\/immadv\/ltaf027\/63883959\/ltaf027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T05:05:17Z","timestamp":1753851917000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/immunotherapyadv\/advance-article\/doi\/10.1093\/immadv\/ltaf027\/8217806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1093\/immadv\/ltaf027","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.10.13.618082","asserted-by":"object"}]},"ISSN":["2732-4303"],"issn-type":[{"value":"2732-4303","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"article-number":"ltaf027"}}